Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/20/2025

Armodafinil Dosage and Safety Considerations

Special Populations

  • For elderly patients, consideration should be given to using lower doses (starting at 100 mg) with close monitoring, as recommended by the American Academy of Sleep Medicine 1
  • Armodafinil is contraindicated in pregnancy based on animal data showing potential fetal harm, though human data are insufficient to determine risk, according to the American Academy of Sleep Medicine 2, 3
  • The medication may reduce the effectiveness of oral contraceptives, necessitating alternative birth control methods, as suggested by the American Academy of Sleep Medicine 2, 3

Efficacy and Monitoring

  • The American Academy of Sleep Medicine suggests armodafinil as a treatment option for narcolepsy in adults (conditional recommendation) 2, 3

Safety and Adverse Effects

  • Armodafinil is an FDA Schedule IV controlled substance due to its potential for abuse or dependency, as reported by the American Academy of Sleep Medicine 2, 3
  • A 2018 report from the armodafinil/modafinil pregnancy registry showed higher rates of major congenital anomalies in children exposed to the drug in utero, according to the American Academy of Sleep Medicine 2, 3

Important Precautions

  • The medication may reduce the effectiveness of hormonal contraceptives, necessitating alternative birth control methods, as suggested by the American Academy of Sleep Medicine 2, 3

REFERENCES

1

Management of Excessive Daytime Sleepiness in Osmotic Demyelination Syndrome [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

2

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

3

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021